USD10
IBRX acciones
Acerca de ImmunityBioImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
USD10
IBRX acciones
Acerca de ImmunityBioImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Estadísticas
VENTANA DE OPERACIÓN
Abierta
CIERRA A LAS
20:00 GMT+0
CAPITALIZACIÓN DE MERCADO
8648,19 M US$
PRECIO DE APERTURA
8,94 US$
BAJO (1Y)
1,83 US$
ALTO (1Y)
8,28 US$
BAJO (24H)
8,70 US$
Alza (24H)
9,32 US$
Volumen (24 h)
13,85 M US$
29,2 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 8,94 US$ | |
1 día | 8,49 US$ | |
1 semana | 8,46 US$ | |
1 mes | 8,63 US$ | |
1 año | 2,71 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora